期刊文献+

多重干预RAAS对大鼠慢性心功能不全心室重构及血钾的影响 被引量:2

Effects of multi-intervention RAAS on ventricular remodeling and serum K^+ concentration in the chronic cardiac insufficiency rats
下载PDF
导出
摘要 目的探讨多重干预RAAS对大鼠慢性心功能不全心室重构及血钾的影响。方法实验采用缩窄大鼠腹主动脉法建立慢性压力负荷致心功能不全动物模型,选6周龄20只雌性SD大鼠,随机分4组(每组5只),B组(手术模型组)、C组(卡托普利组)、D组(卡托普利+缬沙坦组)、E组(卡托普利+缬沙坦+螺内酯组),另随机抽取5只同龄雌性SD大鼠假手术作为对照(A组)。给药8周后用Doppler超声心动图检测大鼠心脏结构和心功能各项参数的变化,放射免疫法测定血浆AngⅡ,ALDO浓度,并生化检测血钾水平。结果腹主动脉结扎后第9周,与A组比较,B组舒张末期室间隔厚度(IVSTD)、舒张末期左室后壁厚度(LVPWTD)、相对室壁厚度(RWT)、左室重量(LVM)、左室重量与体重比(LVM/BW)均显著提高(P<0.05);C、D、E组与B组相比,LVM,LVM/BW下降显著(P<0.05)。各药物干预组(C、D、E)血浆AngⅡ,ALDO水平明显低于B组(P<0.05),以联合应用螺内酯组明显。各药物干预组与A组和B组相比较,血钾水平差异无显著性(P>0.05)。结论联合应用卡托普利、缬沙坦及螺内酯多重干预RAAS能明显改善大鼠慢性心功能不全心室重构,对血钾无明显影响。 Objective To explore the effects of multi-intervention RAAS on ventricular remodeling and serum K+ concentration in the chronic pressure overload heart due to cardiac insufficiency in rats.Methods To establish chronic cardiac insufficiency animal models with suprarenal abdominal aortic banding in rats.Six-week old female Sprague-Dawley rats were enrolled and the suprarenal abdominal aorta was ligated by 4-0 nylon suture against a needle(outer diameter 0.7 mm).Twenty female rats were randomized into four groups(n = 5),including operated rats(group B),and Captopril-treated rats(group C),Captopril + Valsartan treatment rats(group D) and Captopril + Valsartan + Spironolactone treatment rats(group E),which were treated by gavage everyday at the same time for 8 weeks.Another 5 age-matched sham-operated rats were used as control group(group A).Eight weeks after treatment,the changes of heart structure and cardiac function parameters were obtained by echocardiography.The concentrations of angiotensin II(Ang Ⅱ) and aldosterone(ALDO) in plasma were assessed by radioimmunoassay(RIA).The serum K + concentration was detrmined.Results Compared with the shamoperated groups,the interventricular septal thickness end-diastolic(IVSTD),left ventricular posterior wall thickness end-diastolic(LVPWTD),relative wall thickness(RWT),left ventricular mass(LVM),left ventricular mass /body weight(LVM /BW) in the group B were significantly increased(P〈 0.05).In contrast to the operated groups,the LVM,LVM /BW in groups C,D and E decreased significantly(P〈 0.05).Compared with the group B,the Ang Ⅱ and ALDO were significantly decreased in the drugtreated groups(C,D and E groups)(P 〈0.05),especially in the group E.There were no significant changes of the serum K + concentration in all groups(P 〈0.05).Conclusions Multi-intervention RAAS using Captopril,Valsartan and Spironolactone simultaneously are very effective in suppressing ventricular remodeling in chronic cardiac insufficiency rats,but has no effects on the serum K + concentration.
出处 《中国实验动物学报》 CAS CSCD 2011年第1期79-83,共5页 Acta Laboratorium Animalis Scientia Sinica
关键词 肾素-血管紧张素-醛固酮系统 卡托普利 缬沙坦 螺内酯 模型 动物 Renin-angiotensin-aldosterone system Captopril Valsartan Spironolactone Cardiac insufficiency Animal models Rat
  • 相关文献

参考文献17

  • 1Funder JW,Mihailidou AS.Aldosterone and mineralocorticoid receptors:clinical studies and basic biology[J].Mol Cell Endocrinol,2009,301(1-2):2-6.
  • 2Kalidindi SR,Tang WH,Francis GS.Drug insight:aldosterone-receptor antagonists in heart failure ― the journey continues[J].Nat Clin Pract Cardiovasc Med,2007,4(7):368-378.
  • 3Thorsten R,Robert A,Kloner C.Transthoracic echocardiography in rats:evalution of commonly used indices of left ventricular dimensions,contractile performance and hypertrophy in a genetic model of hypertrophic heart failure (SHHFMcc-facp-Rats) in comparison with Wistar rats during aging[J].Basic Res Cardiol,2003,98:275-284.
  • 4Gaasch WH,Delorey DE,St John Sutton MG,et al.Patterns of structural and functional remodeling of the left ventricle in chronic heart failure[J].Am J Cardiol,2008,102(4):459-462.
  • 5宋晓东,辛颖,刘哲,王虎,张竞予,张禅那,惠汝太.压力后负荷增高大鼠心肌肥厚向心力衰竭的转变[J].中国实验动物学报,2007,15(2):86-89. 被引量:11
  • 6Murrakami K,Mizushige K,Noma T,et al.Perindopril effect on uncoupling protein and energy metabolism in failing rat hearts[J].Hypertension,2002,40(3):251-255.
  • 7许立龙,李国杰.大鼠部分心脏疾患模型建立与超声评价心功能进展[J].心血管病学进展,2005,26(4):439-442. 被引量:4
  • 8Uechi M,Tanaka Y,Aramaki Y,et al.Evaluation of the renin-angiotensin systemin cardiac tissues of cats with pressure-overload cardiac hypertrophy[J].AmJ Vet Res,2008,69 (3):343-348.
  • 9Ubaid-Girioli S,Ferreira-Melo SE,Souza LA,et al.Aldosterone escape with diuretic or angiotensin-converting enzyme inhibitor/angiotensin Ⅱ receptor blocker combination therapy in patients with mild to moderate hypertension[J].J Clin Hypertens (Greenwich),2007,9(10):770-774.
  • 10Rump LC.Secondary rise of albuminuria under AT1-receptor blockade-what is the potential role of aldosterone escape[J].Nephrol Dial Transplant,2007,22(1):5-8.

二级参考文献57

  • 1Miller AB, Srivastava P. Angiotensin receptor blockers and aldosterone antagonists in chronic heart failure[J]. Cardiol Clin, 2001,19(2) : 195 -202.
  • 2Weir MR, Dzau VJ. The renin - angiotensin - aldosterone system: a special target for hypertension management[J]. Am J Hypertens, 1999,12(12pt3) :205s - 213s.
  • 3Palmieri EA, Biondi B, Fazio S. Aldosterone receptor blockade in the management of heart failure[J]. Heart Fail Rev, 2002,7(2):205- 219.
  • 4Ddcayre C, Swynghedauw B. Molecular mechanisms of myocardial remodeling, the role of aldosterone[J].J Mol Cell Cardiol,2002,34(12): 1577-1584.
  • 5Urata H, Ganten D, Dishiumura H. Chysmasc-dependent angiotensin Ⅱ forming system in humans[J]. Am J Hypertens, 1996,9:277 - 284.
  • 6Lee AF, Macfadyen RJ, Struthers AD. Neurohormonal reactivation in heart failure patients on chonic ACE inhibitor therapy: a longitudinal study[J]. Eur Heart Fail, 1999,1(4):401-406.
  • 7Simko F, Bada V, Simkova Ⅲ, et al . The significance of aldosterone in chronic heart failure: the RALE study[J]. Vnitr Lek, 2002,48(8):767 - 772.
  • 8Pitt B,Zannad F,Remme WJ,et al.The effect of spironolactone on morbidity and mortality in patients with sever heart failure :Randomized Aldoctone Evaluation Study Investigators[J].N Engl J Med,1999,341:709-717.
  • 9Kurtoglu N,Akdemir R,Yuce M,et al.Left ventricular inflow normal or pseudonormal. A new echocardiographic method:diastolic change of left atrial diameter[J].Echocardiography,2000, 17(7):653-658 .
  • 10Nearchous NS,Tsakiris AK,Lolaka MD,et al.Influence of perindopril on left ventricularglobal performance during the early phase of inferion acute myocardial infarction:assessment by Tei index[J]. Echocardiography,2003,20(4):319-327.

共引文献32

同被引文献28

  • 1俸家富,罗军,李少林.胱抑素C——肾小球滤过率肌酐替代标记物[J].国外医学(临床生物化学与检验学分册),2005,26(3):168-172. 被引量:112
  • 2董梅,孟祥红,佟爱华,李艳艳,吴纯.血清胱抑素C在评价糖尿病患者早期肾损伤中的价值[J].中国实验诊断学,2006,10(6):642-643. 被引量:32
  • 3Cohen L. The cardiorenal syndrome: pathophysiologic crosstalk, outcomes, and treatment targets[J]. Cardiovase Hematol Disord Drug Targets, 2014, 14(3): 170-176.
  • 4Ye X, Wei L, Pei X, et al. Application of ereatinine- and/or cystatin C-based glomerular filtration rate estimation equations in elderly Chinese[J]. Clin Interv Aging, 2014, 11(9): 1539-1549.
  • 5A1-Khabori M, Bhandari S, A1-Rasadi K, et al. Correlation of ironoverload and glomerular filtration rate estimated by cystatin C in patients with I-thalassemia major [J]. Hemoglobin, 2014, 38 (5): 365-368.
  • 6Moreira E Lima R, Navarro LH, Nakamum G, et aL Serum eystatin C is a sensitive early marker for changes in the glomemlar filtration rate in patients undergoing laparoscopic surgery [J]. Clinics (Sao Paulo), 2014, 69(6): 378-383.
  • 7Ronco C, HaapioM, House AA, et al. Cardiorenal syndrome [J]. J Am Coll Cardiol, 2008, 52(19): 1527-1539.
  • 8Ronco c, McCullough P, Anker SD, et al. Cardiorenal syndromes: report from the consensus conference of the acute dialysis quality initiative[J]. Eur Heart J, 2010, 31(6): 703-711.
  • 9Weinfeld MS, Chertow OM, Stevenson LW. Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure[J]. Am Heart J, 1999, 138(2 Pt 1): 285-290.
  • 10Guo X, Qin Y, Zheng K, et al. Improved glomerular filtration rate estimation using new equations combined with standardized cystatin C and creatinine in Chinese adult chronic kidney disease patients[J]. Clin Biochem, 2014, 47(13-14): 1220-1226.

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部